CAS: 1024603-92-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Icrucumab REF: TM-T76866CAS: 1024603-92-6 | > 95% | 211.00 €~928.00 € | Tue 10 Dec 24 |
 | Icrucumab REF: 3D-CLA1267CAS: 1024603-92-6 | - - - | To inquire | Tue 17 Dec 24 |
Icrucumab
CAS:1024603-92-6
Icrucumab, a humanized antibody, inhibits VEGFR-1 and shows antitumor effects, tested in metastatic colon cancer.
Purity:
> 95%
Color and Shape:
Liquid
Molecular weight:
150 kDa
Ref: TM-T76866
| 1mg | 211.00 € | ||
| 5mg | 610.00 € | ||
| 10mg | 928.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ref: 3D-CLA1267
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 17 Dec 2024
